肌酸补充在神经退行性疾病中的潜在作用
1Department of Sport and Exercise Science, Seoul Women's University, Seoul, Republic of Korea.
Physical activity and nutrition
|February 1, 2024
概括
肌酸 (Cr) 支持大脑能量,但临床试验显示神经退行性疾病的混合结果. 需要进一步的研究来确定最佳的肌酸剂量,以促进大脑健康和神经保护.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 肌酸 (Cr) 对于肌肉和中枢神经系统等高需求组织的能量平衡至关重要.
- 通过补充ATP,Cr支持大脑的生物能量,并提供抗氧化和抗丧的好处.
- 虽然对肌肉功能有好处,但Cr在神经系统疾病中的作用需要进一步调查.
研究的目的:
- 审查肌酸在人类,动物和体外模型中的作用,这些模型与神经系统疾病相关.
- 为潜在的治疗应用提供关于理想的肌酸剂量方案的见解.
- 评估当前对肌酸的神经保护潜力的理解.
主要方法:
- 搜索了PubMed和谷歌学者使用术语,如"肌酸和神经障碍"和"肌酸补充和神经退行性疾病.
- 审查文章和检查参考文献,以调查肌酸补充剂和神经退行性疾病之间的关联.
- 综合了体外,动物和临床研究的结论.
主要成果:
- 实验室和动物模型表明,肌酸在某些神经退行性疾病中具有神经保护作用.
- 研究神经退行性疾病的肌酸补充剂的临床试验并未始终产生有利的结果.
- 有证据表明,临床前和临床发现之间存在关于肌酸功效的差异.
结论:
- 优化肌酸剂量对于提高大脑肌酸水平和支持大脑健康至关重要.
- 需要进一步的研究来阐明肌酸在神经退行性疾病中的治疗潜力.
- 建立有效的肌酸饮食可能是管理和治疗神经退行症的关键.
相关概念视频
Role of Neurotransmitters in Memory
557
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
557
Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
126
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
126
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Long-term Potentiation
55.2K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
55.2K


